SUN1
geneOn this page
Also known as KIAA0810FLJ12407
Summary
SUN1 (Sad1 and UNC84 domain containing 1, HGNC:18587) is a protein-coding gene on chromosome 7p22.3, encoding SUN domain-containing protein 1 (O94901). As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex involved in the connection between the nuclear lamina and the cytoskeleton.
This gene is a member of the unc-84 homolog family and encodes a nuclear envelope protein with an Unc84 (SUN) domain. The protein is involved in nuclear anchorage and migration. Alternatively spliced transcript variants have been described.
Source: NCBI Gene 23353 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 693 total
- MANE Select transcript:
NM_001130965
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18587 |
| Approved symbol | SUN1 |
| Name | Sad1 and UNC84 domain containing 1 |
| Location | 7p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA0810, FLJ12407 |
| Ensembl gene | ENSG00000164828 |
| Ensembl biotype | protein_coding |
| OMIM | 607723 |
| Entrez | 23353 |
Gene structure
Transcript identifiers
Ensembl transcripts: 201 — 183 protein_coding, 14 retained_intron, 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000340926, ENST00000389574, ENST00000401592, ENST00000403868, ENST00000405266, ENST00000413171, ENST00000419312, ENST00000421580, ENST00000424128, ENST00000425407, ENST00000427969, ENST00000429178, ENST00000433212, ENST00000435699, ENST00000439679, ENST00000440380, ENST00000450538, ENST00000450881, ENST00000452783, ENST00000457378, ENST00000457598, ENST00000457861, ENST00000459810, ENST00000463848, ENST00000464442, ENST00000467483, ENST00000469755, ENST00000471349, ENST00000475971, ENST00000477950, ENST00000480475, ENST00000483996, ENST00000488628, ENST00000493681, ENST00000497943, ENST00000881147, ENST00000881148, ENST00000881149, ENST00000881150, ENST00000881151, ENST00000881152, ENST00000881153, ENST00000881154, ENST00000881155, ENST00000881156, ENST00000881157, ENST00000881158, ENST00000881159, ENST00000881160, ENST00000881161, ENST00000881162, ENST00000881163, ENST00000881164, ENST00000881165, ENST00000881166, ENST00000881167, ENST00000881168, ENST00000881169, ENST00000881170, ENST00000881171, ENST00000881172, ENST00000881173, ENST00000881174, ENST00000881175, ENST00000881176, ENST00000881177, ENST00000881178, ENST00000881179, ENST00000881180, ENST00000881181, ENST00000916963, ENST00000916964, ENST00000916965, ENST00000916966, ENST00000916967, ENST00000916968, ENST00000916969, ENST00000916970, ENST00000916971, ENST00000916972, ENST00000916973, ENST00000916974, ENST00000916975, ENST00000916976, ENST00000916977, ENST00000916978, ENST00000916979, ENST00000916980, ENST00000916981, ENST00000916982, ENST00000916983, ENST00000916984, ENST00000916985, ENST00000916986, ENST00000916987, ENST00000963073, ENST00000963074, ENST00000963075, ENST00000963076, ENST00000963077, ENST00000963078, ENST00000963079, ENST00000963080, ENST00000963081, ENST00000963082, ENST00000963083, ENST00000963084, ENST00000963085, ENST00000963086, ENST00000963087, ENST00000963088, ENST00000963089, ENST00000963090, ENST00000963091, ENST00000963093, ENST00000963094, ENST00000963096, ENST00000963098, ENST00000963099, ENST00000963100, ENST00000963101, ENST00000963102, ENST00000963103, ENST00000963104, ENST00000963105, ENST00000963106, ENST00000963107, ENST00000963108, ENST00000963109, ENST00000963110, ENST00000963111, ENST00000963112, ENST00000963113, ENST00000963114, ENST00000963115, ENST00000963116, ENST00000963117, ENST00000963118, ENST00000963119, ENST00000963120, ENST00000963121, ENST00000963122, ENST00000963123, ENST00000963124, ENST00000963125, ENST00000963126, ENST00000963127, ENST00000963128, ENST00000963129, ENST00000963130, ENST00000963131, ENST00000963132, ENST00000963133, ENST00000963134, ENST00000963135, ENST00000963136, ENST00000963137, ENST00000963138, ENST00000963139, ENST00000963140, ENST00000963141, ENST00000963142, ENST00000963143, ENST00000963144, ENST00000963145, ENST00000963146, ENST00000963147, ENST00000963148, ENST00000963149, ENST00000963150, ENST00000963151, ENST00000963152, ENST00000963153, ENST00000963154, ENST00000963155, ENST00000963156, ENST00000963157, ENST00000963158, ENST00000963159, ENST00000963160, ENST00000963161, ENST00000963162, ENST00000963163, ENST00000963164, ENST00000963165, ENST00000963166, ENST00000963167, ENST00000963168, ENST00000963169, ENST00000963170, ENST00000963171, ENST00000963172, ENST00000963173, ENST00000963174, ENST00000963175, ENST00000963176, ENST00000963177, ENST00000963178, ENST00000963179, ENST00000963180, ENST00000963181
RefSeq mRNA: 71 — MANE Select: NM_001130965
NM_001130965, NM_001171944, NM_001171945, NM_001171946, NM_001367633, NM_001367634, NM_001367635, NM_001367636, NM_001367638, NM_001367639, NM_001367640, NM_001367641, NM_001367642, NM_001367643, NM_001367644, NM_001367645, NM_001367646, NM_001367647, NM_001367648, NM_001367649, NM_001367651, NM_001367653, NM_001367655, NM_001367658, NM_001367660, NM_001367662, NM_001367664, NM_001367665, NM_001367666, NM_001367667, NM_001367668, NM_001367669, NM_001367670, NM_001367671, NM_001367672, NM_001367673, NM_001367674, NM_001367675, NM_001367676, NM_001367677, NM_001367678, NM_001367679, NM_001367680, NM_001367681, NM_001367682, NM_001367683, NM_001367684, NM_001367685, NM_001367686, NM_001367687, NM_001367688, NM_001367689, NM_001367690, NM_001367691, NM_001367692, NM_001367693, NM_001367694, NM_001367695, NM_001367696, NM_001367697, NM_001367698, NM_001367699, NM_001367700, NM_001367701, NM_001367702, NM_001367703, NM_001367704, NM_001367705, NM_001367706, NM_001367708, NM_025154
CCDS: CCDS43533, CCDS47525, CCDS55078, CCDS55079, CCDS55080, CCDS94043
Canonical transcript exons
ENST00000401592 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001087820 | 852810 | 852952 |
| ENSE00003488547 | 854920 | 855006 |
| ENSE00003524433 | 853409 | 853618 |
| ENSE00003540778 | 851950 | 852043 |
| ENSE00003554707 | 851384 | 851482 |
| ENSE00003569233 | 843206 | 843232 |
| ENSE00003569680 | 841946 | 842130 |
| ENSE00003575416 | 872470 | 872562 |
| ENSE00003596939 | 856358 | 856401 |
| ENSE00003617407 | 869349 | 869516 |
| ENSE00003645360 | 843341 | 843520 |
| ENSE00003661366 | 857828 | 857957 |
| ENSE00003669016 | 860128 | 860382 |
| ENSE00003671366 | 865952 | 866067 |
| ENSE00003684435 | 852609 | 852667 |
| ENSE00003684688 | 861380 | 861464 |
| ENSE00003788014 | 838798 | 838986 |
| ENSE00003846297 | 873215 | 874934 |
| ENSE00003846750 | 832476 | 832601 |
Expression profiles
Bgee: expression breadth ubiquitous, 295 present calls, max score 99.41.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 31.6573 / max 235.8016, expressed in 1809 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 76873 | 31.2118 | 1809 |
| 76876 | 0.2638 | 102 |
| 76875 | 0.1538 | 67 |
| 76874 | 0.0278 | 6 |
Top tissues by expression
295 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 99.41 | gold quality |
| oocyte | CL:0000023 | 99.38 | gold quality |
| mucosa of stomach | UBERON:0001199 | 99.09 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 98.91 | gold quality |
| right uterine tube | UBERON:0001302 | 98.79 | gold quality |
| body of uterus | UBERON:0009853 | 98.64 | gold quality |
| left ovary | UBERON:0002119 | 98.62 | gold quality |
| bronchial epithelial cell | CL:0002328 | 98.61 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 98.58 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 98.51 | gold quality |
| endocervix | UBERON:0000458 | 98.45 | gold quality |
| right ovary | UBERON:0002118 | 98.39 | gold quality |
| skin of abdomen | UBERON:0001416 | 98.38 | gold quality |
| skin of leg | UBERON:0001511 | 98.38 | gold quality |
| cerebellar cortex | UBERON:0002129 | 98.33 | gold quality |
| skin of hip | UBERON:0001554 | 98.29 | gold quality |
| tibial nerve | UBERON:0001323 | 98.24 | gold quality |
| ectocervix | UBERON:0012249 | 98.18 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 98.16 | gold quality |
| cerebellum | UBERON:0002037 | 98.12 | gold quality |
| bronchus | UBERON:0002185 | 98.11 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 98.11 | gold quality |
| popliteal artery | UBERON:0002250 | 98.08 | gold quality |
| tibial artery | UBERON:0007610 | 98.08 | gold quality |
| zone of skin | UBERON:0000014 | 98.06 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 98.00 | gold quality |
| lower esophagus | UBERON:0013473 | 97.99 | gold quality |
| ovary | UBERON:0000992 | 97.96 | gold quality |
| upper leg skin | UBERON:0004262 | 97.94 | gold quality |
| pituitary gland | UBERON:0000007 | 97.90 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-97 | no | 431.09 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP63
miRNA regulators (miRDB)
61 targeting SUN1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-4766-5P | 99.75 | 69.23 | 2662 |
| HSA-MIR-4446-5P | 99.72 | 69.19 | 2544 |
| HSA-MIR-4422 | 99.72 | 72.07 | 2908 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-379-3P | 99.69 | 69.60 | 1524 |
| HSA-MIR-411-3P | 99.69 | 69.63 | 1524 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
Literature-anchored findings (GeneRIF, showing 38)
- Describes cloning and function of C. elegans unc-84 and cloning of human orthologs. (PMID:10375507)
- KIAA0810 is a novel 100-kDa transmembrane protein with similarity to Caenorhabditis elegans Unc-84A and resides in the inner nuclear membrane. It is likely to interact with the nuclear lamina. (PMID:11593002)
- Isolation of a cDNA encoding a mouse homolog of the human SUN1 (UNC84A) gene. (PMID:12036294)
- The Sun1 itself does not require functional A-type lamins for its localisation at the inner nuclear membrane in mammalian cells. (PMID:16079285)
- localization and anchoring of UNC84A is not dependent on the lamin proteins, in contrast to what had been observed for C. elegans UNC-84 (PMID:16445915)
- SUN1 and SUN2 may form a physical interaction between the nuclear envelope and the centrosome (PMID:17132086)
- chromosome de-condensation needs the function of an inner nuclear membrane (INM) protein hsSUN1 and a membrane-associated histone acetyltransferase (HAT), hALP. (PMID:17631499)
- Results suggest that Sun1 represents an important determinant of nuclear pore complex distribution across the nuclear surface. (PMID:17724119)
- perturbations in lamin A-SUN1 and SUN2 protein interactions may underlie the opposing effects of EDMD and HGPS mutations on nuclear and cellular mechanics (PMID:19933576)
- Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development (PMID:20108321)
- These results demonstrate that the interplay between SUN1 and farnesylated prelamin A contributes to nuclear positioning in human myofibers and may be implicated in pathogenetic mechanisms. (PMID:21311568)
- POM121 and Sun1 interact transiently to promote early steps of interphase nuclear pore complexes assembly (PMID:21727197)
- Reduction of SUN1 overaccumulation in LMNA mutant fibroblasts and in cells derived from HGPS patients corrected nuclear defects and cellular senescence. (PMID:22541428)
- Results highlight the interactions at the nuclear envelope where mutations in the EMD and TMPO gene in combination with mutations in SUN1 have an impact on several components of the network. (PMID:24375709)
- Farnesylation of progerin enhances its interaction with SUN1 and reduces SUN1 mobility. (PMID:24522183)
- Codepletion of SUN1/2 slows cell proliferation and results in an accumulation of morphologically defective and disoriented mitotic spindles. (PMID:24662567)
- The Caenorhabditis elegans lamin, LMN-1, is required for nuclear migration and interacts with the nucleoplasmic domain of the SUN protein UNC-84. (PMID:25057012)
- An important role for SUN1 and SUN2 in muscle disease pathogenesis. (PMID:25210889)
- these data support a model whereby mitotic phosphorylation of SUN1 disrupts interactions with nucleoplasmic binding partners, promoting disassembly of the nuclear lamina and, potentially, its chromatin interactions (PMID:25482198)
- Nuclear envelope associated endosome-mediated transfer depends on the nuclear envelope proteins SUN1 and SUN2, as well as the Sec61 translocon complex. (PMID:26356418)
- SUN1 plays a role in hnRNP-involved mRNA export. (PMID:26476453)
- wndchrm revealed a consistent negative correlation between SUN1 expression and the size of nucleoli in human breast cancer tissues. (PMID:26962703)
- SUN1/SUN2 may function redundantly in early HIV-1 infection steps and therefore influence HIV-1 replication and pathogenesis. (PMID:28747499)
- Results provide evidence that SUN1 is involved in mRNA export and this function is regulated by phosphorylation of serine 113 in the N-terminal domain. (PMID:28831067)
- Thus, AID is a conserved functional domain in SUN proteins and this work provides the structural evidence to support the conversation of the AID-mediated autoinhibition of SUN proteins. (PMID:29408528)
- Mechanisms of SUN1 Oligomerization in the Nuclear Envelope (PMID:29539404)
- Low SUN1 expression is associated with HIV infections. (PMID:29643244)
- While Sun1 and Sun2 in HeLa cells are each able to bind KASH-domains, Sun1 is more efficiently incorporated into LINC complexes under normal growth conditions. Furthermore, the balance of Sun1 and Sun2 incorporated into LINC complexes is cell type-specific and is correlated with SRF/Mkl1-dependent gene expression. (PMID:29813079)
- Progerin overexpression increased levels of SUN1, which couples the nucleus to microtubules through nesprin-2G and dynein, and microtubule association with the nucleus. Reducing microtubule-nuclear connections through SUN1 depletion or dynein inhibition rescued the polarity defects. (PMID:30808750)
- SUN1/2 Are Essential for RhoA/ROCK-Regulated Actomyosin Activity in Isolated Vascular Smooth Muscle Cells. (PMID:31935926)
- The SUN1 splicing variants SUN1_888 and SUN1_916 differentially regulate nucleolar structure. (PMID:32931086)
- The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal. (PMID:33686165)
- The SUN1-SPDYA interaction plays an essential role in meiosis prophase I. (PMID:34039995)
- Nuclear restriction of HIV-1 infection by SUN1. (PMID:34580332)
- Homozygous missense mutation in CCDC155 disrupts the transmembrane distribution of CCDC155 and SUN1, resulting in non-obstructive azoospermia and premature ovarian insufficiency in humans. (PMID:35587281)
- Loss of SUN1 function in spermatocytes disrupts the attachment of telomeres to the nuclear envelope and contributes to non-obstructive azoospermia in humans. (PMID:36933034)
- SUN1 facilitates CHMP7 nuclear influx and injury cascades in sporadic amyotrophic lateral sclerosis. (PMID:37639327)
- SUN1 inhibits osteogenesis and promotes adipogenesis of human adipose-derived stem cells by regulating alpha-tubulin and CD36 expression. (PMID:39383106)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sun1b | ENSDARG00000055350 |
| danio_rerio | sun1a | ENSDARG00000077178 |
| mus_musculus | Sun1 | ENSMUSG00000036817 |
| rattus_norvegicus | Sun1 | ENSRNOG00000001299 |
Paralogs (4): SPAG4 (ENSG00000061656), SUN2 (ENSG00000100242), SUN3 (ENSG00000164744), SUN5 (ENSG00000167098)
Protein
Protein identifiers
SUN domain-containing protein 1 — O94901 (reviewed: O94901)
Alternative names: Protein unc-84 homolog A, Sad1/unc-84 protein-like 1
All UniProt accessions (14): A0A146IHP0, A0A8I5G938, C9JJU6, C9JK55, C9JR15, C9JS54, C9K051, E9PHI4, O94901, H0Y6N5, H0Y742, H7C019, H7C2K3, H7C3X3
UniProt curated annotations — full annotation on UniProt →
Function. As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex involved in the connection between the nuclear lamina and the cytoskeleton. The nucleocytoplasmic interactions established by the LINC complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and positioning. Required for interkinetic nuclear migration (INM) and essential for nucleokinesis and centrosome-nucleus coupling during radial neuronal migration in the cerebral cortex and during glial migration. Involved in telomere attachment to nuclear envelope in the prophase of meiosis implicating a SUN1/2:KASH5 LINC complex in which SUN1 and SUN2 seem to act at least partial redundantly. Required for gametogenesis and involved in selective gene expression of coding and non-coding RNAs needed for gametogenesis. Helps to define the distribution of nuclear pore complexes (NPCs). Required for efficient localization of SYNE4 in the nuclear envelope. May be involved in nuclear remodeling during sperm head formation in spermatogenesis. May play a role in DNA repair by suppressing non-homologous end joining repair to facilitate the repair of DNA cross-links.
Subunit / interactions. Core component of the LINC complex which is composed of inner nuclear membrane SUN domain-containing proteins coupled to outer nuclear membrane KASH domain-containing nesprins. SUN and KASH domain-containing proteins seem to bind each other promiscuously; however, differentially expression of LINC complex constituents is giving rise to specific assemblies. At least SUN1/2-containing core LINC complexes are proposed to be hexameric composed of three protomers of each KASH and SUN domain-containing protein. Interacts with KASH5 (via the last 22 amino acids); this interaction mediates KASH5 telomere localization by forming a SUN1:KASH5 LINC complex. May interact with SYNE3. Interacts with SYNE2 and SYNE1; probably forming respective LINC complexes. Interacts with A-type lamin with a strong preference for unprocessed A-type lamin compared with the mature protein. Interaction with lamins B1 and C is hardly detectable. Interacts with NAT10. Interacts with EMD and TSNAX. Associates with the nuclear pore complex (NPC). Interacts with CCDC79/TERB1; promoting the accumulation of the LINC complex complexes at the telomere-nuclear envelope attachment sites. Interacts (via KASH domain) with TMEM258.
Subcellular location. Nucleus inner membrane.
Post-translational modifications. The disulfide bond with KASH domain-containing nesprins is required for stability of the respective LINC complexes under tensile forces.
Domain organisation. The coiled coil domains differentially mediate trimerization required for binding to nesprins and are proposed to dynamically regulate the oligomeric state by locking the SUN domain in an inactive confirmation. The coiled coil domains are proposed to be involved in load-bearing and force transmission from the cytoskeleton. The SUN domain may play a role in nuclear anchoring and/or migration.
Isoforms (8)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O94901-8 | 1 | yes |
| O94901-2 | 2 | |
| O94901-3 | 3 | |
| O94901-4 | 4 | |
| O94901-5 | 5 | |
| O94901-6 | 6 | |
| O94901-7 | 7 | |
| O94901-9 | 8 |
RefSeq proteins (71): NP_001124437, NP_001165415, NP_001165416, NP_001165417, NP_001354562, NP_001354563, NP_001354564, NP_001354565, NP_001354567, NP_001354568, NP_001354569, NP_001354570, NP_001354571, NP_001354572, NP_001354573, NP_001354574, NP_001354575, NP_001354576, NP_001354577, NP_001354578, NP_001354580, NP_001354582, NP_001354584, NP_001354587, NP_001354589, NP_001354591, NP_001354593, NP_001354594, NP_001354595, NP_001354596, NP_001354597, NP_001354598, NP_001354599, NP_001354600, NP_001354601, NP_001354602, NP_001354603, NP_001354604, NP_001354605, NP_001354606, NP_001354607, NP_001354608, NP_001354609, NP_001354610, NP_001354611, NP_001354612, NP_001354613, NP_001354614, NP_001354615, NP_001354616, NP_001354617, NP_001354618, NP_001354619, NP_001354620, NP_001354621, NP_001354622, NP_001354623, NP_001354624, NP_001354625, NP_001354626, NP_001354627, NP_001354628, NP_001354629, NP_001354630, NP_001354631, NP_001354632, NP_001354633, NP_001354634, NP_001354635, NP_001354637, NP_079430 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012919 | SUN_dom | Domain |
| IPR032680 | SUN1_N | Domain |
| IPR040994 | Sun_CC2 | Domain |
| IPR045119 | SUN1-5 | Family |
Pfam: PF07738, PF09387, PF18580
UniProt features (58 total): strand 13, splice variant 11, sequence conflict 8, modified residue 5, helix 5, region of interest 4, sequence variant 3, topological domain 2, chain 1, disulfide bond 1, cross-link 1, transmembrane region 1, turn 1, domain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
8 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6R2I | X-RAY DIFFRACTION | 1.54 |
| 8B46 | X-RAY DIFFRACTION | 1.67 |
| 6R15 | X-RAY DIFFRACTION | 1.82 |
| 8B5X | X-RAY DIFFRACTION | 1.98 |
| 8AU0 | X-RAY DIFFRACTION | 2.07 |
| 7Z8Y | X-RAY DIFFRACTION | 2.29 |
| 6R16 | X-RAY DIFFRACTION | 2.75 |
| 7E34 | X-RAY DIFFRACTION | 3.19 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O94901-F1 | 60.99 | 0.18 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (6): 138, 344, 195, 333, 48, 100
Disulfide bonds (1): 630
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-1221632 | Meiotic synapsis |
| R-HSA-1474165 | Reproduction |
| R-HSA-1500620 | Meiosis |
| R-HSA-1640170 | Cell Cycle |
MSigDB gene sets: 247 (showing top):
GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, GOBP_CHROMOSOME_ORGANIZATION, REACTOME_MEIOTIC_SYNAPSIS, GOBP_CHROMOSOME_LOCALIZATION, DARWICHE_SKIN_TUMOR_PROMOTER_UP, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_UP, GOBP_NEUROGENESIS, DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP, GOBP_MALE_GAMETE_GENERATION, GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE, GOBP_FOREBRAIN_DEVELOPMENT, chr7p22, GOBP_FOREBRAIN_CELL_MIGRATION, GOBP_ORGANELLE_FISSION
GO Biological Process (10): ossification (GO:0001503), homologous chromosome pairing at meiosis (GO:0007129), spermatogenesis (GO:0007283), response to mechanical stimulus (GO:0009612), nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817), centrosome localization (GO:0051642), meiotic attachment of telomere to nuclear envelope (GO:0070197), nuclear matrix anchoring at nuclear membrane (GO:0090292), cell differentiation (GO:0030154), meiotic cell cycle (GO:0051321)
GO Molecular Function (5): lamin binding (GO:0005521), identical protein binding (GO:0042802), protein-membrane adaptor activity (GO:0043495), cytoskeleton-nuclear membrane anchor activity (GO:0140444), protein binding (GO:0005515)
GO Cellular Component (8): chromosome, telomeric region (GO:0000781), nuclear envelope (GO:0005635), nuclear inner membrane (GO:0005637), cytoplasm (GO:0005737), nuclear membrane (GO:0031965), meiotic nuclear membrane microtubule tethering complex (GO:0034993), nucleus (GO:0005634), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Meiosis | 1 |
| Reproduction | 1 |
| Cell Cycle | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein binding | 2 |
| nucleus | 2 |
| cellular anatomical structure | 2 |
| multicellular organismal process | 1 |
| homologous chromosome segregation | 1 |
| chromosome organization involved in meiotic cell cycle | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| response to external stimulus | 1 |
| response to abiotic stimulus | 1 |
| modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 1 |
| nuclear migration along microtubule | 1 |
| microtubule organizing center localization | 1 |
| meiotic telomere tethering at nuclear periphery | 1 |
| chromosome attachment to the nuclear envelope | 1 |
| meiotic cell cycle process | 1 |
| nuclear matrix organization | 1 |
| maintenance of protein location in nucleus | 1 |
| cellular developmental process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| protein-macromolecule adaptor activity | 1 |
| protein-membrane adaptor activity | 1 |
| binding | 1 |
| chromosomal region | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| organelle inner membrane | 1 |
| nuclear membrane | 1 |
| intracellular anatomical structure | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| microtubule organizing center attachment site | 1 |
| nuclear membrane microtubule tethering complex | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1502 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SUN1 | SYNE2 | Q8WXH0 | 999 |
| SUN1 | SYNE1 | Q8NF91 | 999 |
| SUN1 | EMD | P50402 | 997 |
| SUN1 | KASH5 | Q8N6L0 | 995 |
| SUN1 | LMNA | P02545 | 978 |
| SUN1 | TERB1 | Q8NA31 | 968 |
| SUN1 | SUN2 | Q9UH99 | 966 |
| SUN1 | TMEM201 | Q5SNT2 | 950 |
| SUN1 | NUP153 | P49790 | 919 |
| SUN1 | LMNB1 | P20700 | 894 |
| SUN1 | SYNE4 | Q8N205 | 855 |
| SUN1 | LMNB2 | Q03252 | 842 |
| SUN1 | SYNE3 | Q6ZMZ3 | 838 |
| SUN1 | TERB2 | Q8NHR7 | 826 |
| SUN1 | H0YEC1 | H0YEC1 | 815 |
IntAct
125 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FBXO28 | TRAF5 | psi-mi:“MI:0914”(association) | 0.740 |
| SUN1 | SYNE1 | psi-mi:“MI:0407”(direct interaction) | 0.710 |
| SYNE1 | SUN1 | psi-mi:“MI:0914”(association) | 0.710 |
| SUN1 | SYNE4 | psi-mi:“MI:0407”(direct interaction) | 0.650 |
| STX12 | SNAP23 | psi-mi:“MI:0914”(association) | 0.640 |
| SUN1 | KASH5 | psi-mi:“MI:0407”(direct interaction) | 0.620 |
| SUN1 | IRAG2 | psi-mi:“MI:0407”(direct interaction) | 0.620 |
| IRAG2 | SUN1 | psi-mi:“MI:0407”(direct interaction) | 0.620 |
| SUN1 | SUN1 | psi-mi:“MI:0407”(direct interaction) | 0.610 |
| EFTUD2 | SART1 | psi-mi:“MI:0914”(association) | 0.610 |
BioGRID (217): SUN1 (Affinity Capture-MS), ZNF507 (Affinity Capture-MS), TYW5 (Affinity Capture-MS), TRIP6 (Affinity Capture-MS), SUN1 (Affinity Capture-MS), SUN1 (Affinity Capture-MS), SUN1 (Affinity Capture-MS), SUN1 (Affinity Capture-MS), SUN1 (Affinity Capture-MS), SUN1 (Affinity Capture-MS), SUN1 (Proximity Label-MS), SUN1 (Proximity Label-MS), SUN1 (Affinity Capture-MS), SUN1 (Proximity Label-MS), SUN1 (Affinity Capture-MS)
ESM2 similar proteins: A0A8M9PDM1, A0A8M9QN10, A1L3I3, A2AWH2, A2CI97, A2CI98, A4IFM1, A4IHZ3, A7E2V4, A7E305, B1AL88, B6CKP4, E7F211, F8W3R9, O55034, O94901, P35054, P51864, P86275, P98153, P98154, Q0VCT2, Q3UHH1, Q498C7, Q4KM46, Q4TUC0, Q58T08, Q5EB20, Q5HZE8, Q5RD34, Q5VUB5, Q6UW32, Q6V9Y8, Q7TNI2, Q7Z5A8, Q80ZA7, Q86VZ4, Q8CB67, Q8CCS2, Q8N0W7
Diamond homologs: A0A0B4KEE4, O55034, O94901, Q09825, Q0II64, Q20745, Q5SS91, Q8BJS4, Q8TAQ9, Q8TC36, Q95LV7, Q9D666, Q9DA32, Q9JJF2, Q9NPE6, Q9UH99, Q9SG79, Q558Z2, Q9FF75
SIGNOR signaling
11 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| PLK1 | “down-regulates activity” | SUN1 | phosphorylation |
| CDK1 | “down-regulates activity” | SUN1 | phosphorylation |
| PKC | “down-regulates activity” | SUN1 | phosphorylation |
| SUN1 | “up-regulates activity” | NUP153 | binding |
| SUN1 | “up-regulates activity” | NXF1 | binding |
| SUN1 | “up-regulates activity” | TERB1 | binding |
| SUN1 | “up-regulates activity” | MAJIN | binding |
| SUN1 | “up-regulates activity” | SPDYA | binding |
| TP63 | “up-regulates quantity by expression” | SUN1 | “transcriptional regulation” |
| SUN1 | “form complex” | “LINC complex” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
693 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 333 |
| Likely benign | 238 |
| Benign | 77 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
6070 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:816672:AGGT:A | donor_loss | 1.0000 |
| 7:816673:GGTG:G | donor_loss | 1.0000 |
| 7:816674:G:C | donor_loss | 1.0000 |
| 7:832493:C:A | acceptor_gain | 1.0000 |
| 7:832503:A:AG | acceptor_gain | 1.0000 |
| 7:832503:AGTAT:A | acceptor_gain | 1.0000 |
| 7:832504:G:GG | acceptor_gain | 1.0000 |
| 7:832504:GTATG:G | acceptor_gain | 1.0000 |
| 7:838796:A:AG | acceptor_gain | 1.0000 |
| 7:838797:G:GT | acceptor_gain | 1.0000 |
| 7:838797:GTTCC:G | acceptor_gain | 1.0000 |
| 7:838983:CCAGG:C | donor_loss | 1.0000 |
| 7:838985:AGGT:A | donor_loss | 1.0000 |
| 7:841941:CTTA:C | acceptor_loss | 1.0000 |
| 7:841944:A:AG | acceptor_gain | 1.0000 |
| 7:841945:G:GG | acceptor_gain | 1.0000 |
| 7:841945:GA:G | acceptor_gain | 1.0000 |
| 7:841945:GAA:G | acceptor_gain | 1.0000 |
| 7:841945:GAAC:G | acceptor_gain | 1.0000 |
| 7:841945:GAACA:G | acceptor_gain | 1.0000 |
| 7:842127:TGGG:T | donor_gain | 1.0000 |
| 7:842128:GGG:G | donor_gain | 1.0000 |
| 7:842128:GGGG:G | donor_gain | 1.0000 |
| 7:842129:GG:G | donor_gain | 1.0000 |
| 7:842129:GGG:G | donor_gain | 1.0000 |
| 7:842130:GG:G | donor_gain | 1.0000 |
| 7:842131:G:GG | donor_gain | 1.0000 |
| 7:842132:T:G | donor_loss | 1.0000 |
| 7:843448:G:GT | donor_gain | 1.0000 |
| 7:843516:AAAAT:A | donor_gain | 1.0000 |
AlphaMissense
5111 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000023864 (7:867836 A>G), RS1000039222 (7:840487 C>T), RS1000054903 (7:871715 CAG>C), RS1000125234 (7:837645 G>C), RS1000139778 (7:868027 C>T), RS1000176324 (7:872586 C>A,G,T), RS1000221813 (7:859083 G>A), RS1000253980 (7:842907 G>A), RS1000295227 (7:849806 G>C), RS1000297020 (7:872745 A>C), RS1000312973 (7:858896 T>C), RS1000362023 (7:817054 G>A,C), RS1000364022 (7:847237 C>T), RS1000492509 (7:863312 G>A), RS1000517194 (7:823696 T>A)
Disease associations
OMIM: gene MIM:607723 | disease phenotypes: MIM:310300
GenCC curated gene-disease
Mondo (1): Emery-Dreifuss muscular dystrophy (MONDO:0016830)
Orphanet (1): Emery-Dreifuss muscular dystrophy (Orphanet:261)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004070_14 | Cerebrospinal P-tau181p levels | 5.000000e-07 |
| GCST004864_43 | Perceived unattractiveness to mosquitoes | 6.000000e-06 |
| GCST006061_204 | Atrial fibrillation | 5.000000e-08 |
| GCST90002404_277 | Red cell distribution width | 2.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004763 | p-tau measurement |
| EFO:0008380 | perceived unattractiveness to mosquitos measurement |
| EFO:0009188 | Red cell distribution width |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D020389 | Muscular Dystrophy, Emery-Dreifuss | C05.651.534.500.350; C10.668.491.175.500.350; C16.320.322.625; C16.320.577.350 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
43 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, decreases methylation | 3 |
| Acetaminophen | increases expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| Cadmium Chloride | decreases expression, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| alpha-pinene | affects cotreatment, decreases expression, increases abundance | 1 |
| bisphenol A | increases methylation, affects cotreatment | 1 |
| trichostatin A | affects expression | 1 |
| arsenite | decreases reaction, affects binding | 1 |
| sodium arsenite | decreases expression | 1 |
| methacrylaldehyde | affects cotreatment, decreases expression, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| AM 251 | decreases expression | 1 |
| K 7174 | increases expression | 1 |
| bisphenol S | affects cotreatment, decreases methylation | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Fulvestrant | increases methylation, decreases methylation, affects cotreatment | 1 |
| Acrolein | affects cotreatment, decreases expression, increases abundance | 1 |
| Air Pollutants | affects cotreatment, decreases expression, increases abundance | 1 |
| Benztropine | affects cotreatment, decreases expression | 1 |
| Cannabidiol | affects cotreatment, decreases expression | 1 |
| Copper | affects binding, increases expression | 1 |
| Cuprizone | affects cotreatment, decreases expression | 1 |
| Disulfiram | affects binding, increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_C7YP | HAP1 SUN1 (-) SUN2 (-) | Cancer cell line | Male |
| CVCL_C7YQ | HAP1 SUN1 (-) 1 | Cancer cell line | Male |
| CVCL_E2L8 | HAP1 SUN1 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT01403402 | Not specified | RECRUITING | Congenital Muscle Disease Study of Patient and Family Reported Medical Information |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Emery-Dreifuss muscular dystrophy